# SAB Biotherapeutics receives Australian approval to commence Phase 1 clinical trial of SAB-142
**FDA Update**

**2023-10-19 12:41**

**https://www.ainvest.com/news/sab-biotherapeutics-receives-australian-approval-to-commence-phase-1-clinical-trial-of-sab-142-23101000151a8cdcf91543ba/**

SAB Biotherapeutics receives Australian approval to commence Phase 1 clinical trial of SAB-142